AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2018
Mar 2, 2018
35124_dirs_2018-03-02_981e8aad-4ca0-4843-8c7e-853f28eaaf11.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2018-02-20
Reporting Person: Hooper Robert W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-20 | Celsion Corporation Common Stock | P | 13625 | $2.18 | Acquired | 15687 | Direct |
Footnotes
F1: The shares were purchased on the open market.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18